Updated dental Covid SOP in England
REVISED infection prevention control (IPC) requirements for dental settings have been published by the UK Government and this has prompted NHS England to update the standard operating procedure (SOP) for practices.
Lowering the temperature in hostile patient encounters
Risk adviser Alan Frame offers advice on dealing with aggressive and violent patients
Complaints handling: Proactive response to patient complaints
Should practices consider monitoring social media forums to counter misinformation with factual evidence and advice?
Risk: What's up with WhatsApp
Using messaging apps and the associated risks in relation to maintaining professional standards
Employment law: Sexual harassment in the workplace
Employment law adviser Liz Symon offers advice on preventing and dealing with sexual harassment in the workplace
Call log
These cases are based on actual calls made to MDDUS advisers and are published here to highlight common challenges within dental practice. Details have been changed to maintain confidentiality.
Insight Dental Q4 2021
In this issue:
- YourHalo
- Call log
- Employment law: Sexual harassment in the workplace
- Risk: What's up with WhatsApp
- Complaints handling: Proactive response to patient complaints
- Lowering the temperature in hostile patient encounters
- Breaking up is hard to do
- Finding PPE that's fit for all
- Case study: Beyond what's reasonable
- Case study: Lip trauma
- Case study: Emergency backlog
- Legal: Being a competent expert witness
- Ethics: On meeting ethical distress
- Book choice: The Sleeping Beauties - And Other Stories of Mystery Illness
- Vignette: Pat O'Callaghan (1906-1991)
YourHalo
Dental adviser Neena Manek looks at the broad challenges dentists have faced over the past 20 months – and how this has prompted MDDUS to launch a wellbeing service for members
Updated long-Covid guidance published
GUIDANCE for treating patients with long Covid has been updated jointly by NICE, SIGN and the Royal College of GPs.
Covid-19 boosters offer significant protection
A BOOSTER dose with the Pfizer-BioNTech Covid-19 vaccine offers over 93 per cent protection against symptomatic infection in adults aged 50 and over who have had their primary jabs, according to a study published the UK Health Security Agency.